As of Feb 17
| +0.31 / +0.26%|
The 14 analysts offering 12-month price forecasts for Incyte Corp have a median target of 135.00, with a high estimate of 149.00 and a low estimate of 90.00. The median estimate represents a +12.04% increase from the last price of 120.49.
The current consensus among 16 polled investment analysts is to Buy stock in Incyte Corp. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.